Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium Targeting the PI3-Kinase Pathway in Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukazawa, H.
Right arrow Articles by Uehara, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukazawa, H.
Right arrow Articles by Uehara, Y.
Mol Cancer Ther. 2004;3:1281-1288
© 2004 American Association for Cancer Research

BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors

Hidesuke Fukazawa1, Kohji Noguchi1, Atsuko Masumi2, Yuko Murakami1 and Yoshimasa Uehara1

Departments of 1 Bioactive Molecules and 2 Safety Research on Blood and Biologics, National Institute of Infectious Diseases, Tokyo, Japan

Requests for reprints: Hidesuke Fukazawa, Department of Bioactive Molecules, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan. Phone: 81-3-5285-1111; Fax: 81-3-5285-1272. E-mail: fukazawa{at}nih.go.jp

Loss of contact with substratum triggers apoptosis in many normal cell types, a phenomenon termed anoikis. We reported previously that mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors induced apoptosis in nonanchored MDA-MB231 and HBC4 human breast cancer cells, whereas anchored cells remained viable. Here, we report that activation of the BH3-only protein BimEL is the major mechanism for induction of anoikis sensitivity by MEK inhibitors in MDA-MB231 and HBC4 cells. On treatment with MEK inhibitors, BimEL in MDA-MB231 and HBC4 cells rapidly increased, irrespective of the state of anchorage. However, it translocated to mitochondria only in nonanchored cells, explaining why attached cells remain viable. MDA-MB231 and HBC4 cells had exceedingly low basal levels of BimEL compared with other breast cancer cells, suggesting that maintenance of low BimEL amount is important for survival of these cells. MEK inhibitors also induced the electrophoretic mobility shift of BimEL, indicative of reduced phosphorylation. In vitro, BimEL was phosphorylated by extracellular signal-regulated kinase on Ser69, which resides in the BimEL-specific insert region. Using phosphospecific antibody against this site, we show that this residue is actually phosphorylated in cells. We also show that phosphorylation of Ser69 promotes ubiquitination of BimEL. We conclude that MEK inhibitors sensitize MDA-MB231 and HBC4 cells to anoikis by blocking phosphorylation and hence degradation of BimEL, a mechanism that these cells depend on to escape anoikis.


Grant support: Ministry of Education, Culture, Science, Sports, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; and Japan Society for Promotion of Sciences.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 5/26/04; revised 8/ 3/04; accepted 8/11/04.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. Zhang, G. Z. Cheng, J. Gong, U. Hermanto, C. S. Zong, J. Chan, J. Q. Cheng, and L.-H. Wang
RACK1 and CIS Mediate the Degradation of BimEL in Cancer Cells
J. Biol. Chem., June 13, 2008; 283(24): 16416 - 16426.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
V. Labi, M. Erlacher, S. Kiessling, C. Manzl, A. Frenzel, L. O'Reilly, A. Strasser, and A. Villunger
Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates {gamma} irradiation-induced thymic lymphoma development
J. Exp. Med., March 17, 2008; 205(3): 641 - 655.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Uehara, Y. Matsuoka, and A. Tsubura
Mesothelin Promotes Anchorage-Independent Growth and Prevents Anoikis via Extracellular Signal-Regulated Kinase Signaling Pathway in Human Breast Cancer Cells
Mol. Cancer Res., February 1, 2008; 6(2): 186 - 193.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. T. Woods, H. Yamaguchi, F. Y. Lee, K. N. Bhalla, and H.-G. Wang
Anoikis, Initiated by Mcl-1 Degradation and Bim Induction, Is Deregulated during Oncogenesis
Cancer Res., November 15, 2007; 67(22): 10744 - 10752.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
S. N. Anderson, D. L. Towne, D. J. Burns, and U. Warrior
A High-Throughput Soft Agar Assay for Identification of Anticancer Compound
J Biomol Screen, October 1, 2007; 12(7): 938 - 945.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.